• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺瘤。临床病理综述。

Thymoma. A clinicopathologic review.

作者信息

Lewis J E, Wick M R, Scheithauer B W, Bernatz P E, Taylor W F

机构信息

Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905.

出版信息

Cancer. 1987 Dec 1;60(11):2727-43. doi: 10.1002/1097-0142(19871201)60:11<2727::aid-cncr2820601125>3.0.co;2-d.

DOI:10.1002/1097-0142(19871201)60:11<2727::aid-cncr2820601125>3.0.co;2-d
PMID:3677008
Abstract

The clinical and pathologic features of 283 patients with thymoma treated at the Mayo Clinic (147 female and 136 male; ages 16 years to 90 years; mean, 52 years) were examined. Forty-six percent of the patients had myasthenia gravis and 10% had other paraneoplastic phenomena. The tumors were locally invasive at operation in 32%, including 6% with metastasis to lung or pleura. Intrathoracic recurrence was noted postoperatively in 15% of those who had total excision and distant metastasis developed in 3% of patients. Thirteen percent died of their thymomas and 16% died of myasthenia. Overall 5-year survival was 67% and 10-year survival was 53%. Poor prognostic factors included presence of tumor-related symptoms, large tumor size, local invasion or metastasis in initial operation, and predominantly epithelial histologic features. Although true thymomas are composed of cytologically benign elements, they show a propensity for local invasion and intrathoracic recurrence. They rarely metastasize outside the thorax.

摘要

对梅奥诊所收治的283例胸腺瘤患者(147例女性,136例男性;年龄16岁至90岁;平均52岁)的临床和病理特征进行了检查。46%的患者患有重症肌无力,10%的患者有其他副肿瘤现象。32%的肿瘤在手术时呈局部浸润性,其中6%伴有肺或胸膜转移。在接受全切除的患者中,15%术后出现胸内复发,3%的患者发生远处转移。13%的患者死于胸腺瘤,16%的患者死于重症肌无力。总体5年生存率为67%,10年生存率为53%。不良预后因素包括存在肿瘤相关症状、肿瘤体积大、初次手术时局部浸润或转移以及主要为上皮组织学特征。虽然真正的胸腺瘤由细胞学上良性的成分组成,但它们有局部浸润和胸内复发的倾向。它们很少转移至胸部以外。

相似文献

1
Thymoma. A clinicopathologic review.胸腺瘤。临床病理综述。
Cancer. 1987 Dec 1;60(11):2727-43. doi: 10.1002/1097-0142(19871201)60:11<2727::aid-cncr2820601125>3.0.co;2-d.
2
[A comparative clinical and pathological study on the classification and prognostic features of 57 thymomas. II. prognostic features (author's transl)].
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978 Jan 26;91(1):103-15. doi: 10.1007/BF00305976.
3
Thymoma.胸腺瘤
Mayo Clin Proc. 1993 Nov;68(11):1110-23. doi: 10.1016/s0025-6196(12)60907-0.
4
Two cases of repeatedly recurrent atypical thymoma.
Chest. 1999 Jan;115(1):282-5. doi: 10.1378/chest.115.1.282.
5
Thymomas.
Cancer. 1977 May;39(5):2142-57. doi: 10.1002/1097-0142(197705)39:5<2142::aid-cncr2820390531>3.0.co;2-q.
6
[A clinicopathologic study of thymomas: a review of 52 cases, with particular reference to results of treatment].胸腺瘤的临床病理研究:52例病例回顾,特别提及治疗结果
Kyobu Geka. 1993 Jan;46(1):13-20.
7
[Thymoma implants in the pleura as a variant of intrathoracic recurrence].
Grud Serdechnososudistaia Khir. 1993 Nov-Dec(6):60-4.
8
Clinical and pathologic predictors of survival in patients with thymoma.胸腺瘤患者生存的临床和病理预测因素
Ann Surg. 1999 Oct;230(4):562-72; discussion 572-4. doi: 10.1097/00000658-199910000-00012.
9
Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases.胸腺瘤。200例临床分期、组织学特征及生存情况的比较研究。
Cancer. 1985 Mar 1;55(5):1074-86. doi: 10.1002/1097-0142(19850301)55:5<1074::aid-cncr2820550524>3.0.co;2-t.
10
Malignant thymoma: a review of 44 cases.
Changgeng Yi Xue Za Zhi. 1997 Sep;20(3):174-80.

引用本文的文献

1
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma.剑突下及肋弓下胸腔镜胸腺切除术治疗胸腺瘤专家共识
Thorac Cancer. 2025 Jun;16(12):e70094. doi: 10.1111/1759-7714.70094.
2
Surgical management of thymic tumors: a narrative review with focus on robotic-assisted surgery.胸腺肿瘤的外科治疗:一项以机器人辅助手术为重点的叙述性综述
Mediastinum. 2024 Nov 7;8:48. doi: 10.21037/med-24-17. eCollection 2024.
3
Rare Thymoma With Solitary Liver Metastasis.罕见胸腺瘤伴孤立性肝转移
ACG Case Rep J. 2024 Nov 27;11(12):e01562. doi: 10.14309/crj.0000000000001562. eCollection 2024 Dec.
4
Update on thymic epithelial tumors: a narrative review.胸腺上皮肿瘤的最新进展:一篇叙述性综述
Mediastinum. 2024 Apr 26;8:33. doi: 10.21037/med-23-47. eCollection 2024.
5
TNM Staging System in Thymoma: A Critical Appraisal?胸腺瘤的TNM分期系统:一项批判性评估?
J Clin Med. 2024 Jan 21;13(2):610. doi: 10.3390/jcm13020610.
6
Incidence of second malignancies in patients with thymic carcinoma and thymic neuroendocrine tumor.胸腺癌和胸神经内分泌肿瘤患者的第二恶性肿瘤发生率。
J Cancer Res Clin Oncol. 2024 Jan 16;150(1):11. doi: 10.1007/s00432-023-05522-3.
7
Case Reports: A role of postoperative radiation therapy in completely resected early stage intrathyroid thymic carcinoma: a case report and literature review of the diagnosis and treatment.病例报告:术后放疗在完全切除的早期甲状腺内胸腺癌中的作用:一例病例报告及诊断与治疗的文献综述
Front Oncol. 2023 Oct 2;13:1234961. doi: 10.3389/fonc.2023.1234961. eCollection 2023.
8
Review of clinical and diagnostic imaging of the thymus: from age-related changes to thymic tumors and everything in between.胸腺的临床和诊断影像学评价:从与年龄相关的变化到胸腺瘤,以及其间的一切。
Jpn J Radiol. 2024 Mar;42(3):217-234. doi: 10.1007/s11604-023-01497-w. Epub 2023 Oct 6.
9
Differentiating invasive thymic epithelial tumors from mediastinal lung cancer using spectral CT parameters.利用能谱 CT 参数鉴别侵袭性胸腺瘤与纵隔肺癌。
Jpn J Radiol. 2023 Sep;41(9):973-982. doi: 10.1007/s11604-023-01428-9. Epub 2023 Apr 18.
10
Thymic Epithelial Tumors: An Evolving Field.胸腺上皮肿瘤:一个不断发展的领域。
Life (Basel). 2023 Jan 22;13(2):314. doi: 10.3390/life13020314.